Literature DB >> 9218603

IL-4 and IL-10 modulation of CD40-mediated signaling of monocyte IL-1beta synthesis and rescue from apoptosis.

J C Poe1, D H Wagner, R W Miller, R D Stout, J Suttles.   

Abstract

Previous studies have demonstrated that the interaction of CD40 on monocytes with CD40 ligand, present on activated CD4+ T cells, induces monocyte inflammatory cytokine synthesis and rescues monocytes from apoptosis. These findings suggest a role for CD40 signaling of monocyte activation in the maintenance and/or exacerbation of nonseptic (e.g., autoimmune) inflammatory responses. In the present study the effects of the modulatory cytokines IL-4 and IL-10 on CD40-mediated signaling of monocyte IL-1beta synthesis and rescue from apoptosis were examined. Both IL-4 and IL-10 decreased CD40-dependent IL-1beta synthesis in a dose-dependent manner individually and synergized in this effect when used concurrently, with minimal effect on CD40 surface expression. CD40 signaling of IL-1beta synthesis was shown to be dependent on the induction of protein tyrosine kinase (PTK) activity, and both IL-4 and IL-10 diminished CD40-mediated tyrosine phosphorylation of monocyte cellular proteins. However, IL-4, but not IL-10, blocked CD40-mediated rescue from apoptosis, an event that we have demonstrated previously to be dependent on PTK activity as well. Together these results suggest that in monocytes 1) both IL-4 and IL-10 target CD40-induced PTK activity in the down-regulation of IL-1beta synthesis; and 2) IL-4 and IL-10 have divergent effects on the CD40 signaling pathway, in that these cytokines are synergistic with respect to their abilities to inhibit CD40-mediated IL-1beta synthesis and differ in their abilities to block CD40-mediated rescue from apoptosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9218603

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1).

Authors:  K D Brown; B S Hostager; G A Bishop
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

2.  Contribution of interleukin-12 (IL-12) and the CD28/B7 and CD40/CD40 ligand pathways to the development of a pathological T-cell response in IL-10-deficient mice.

Authors:  Ulrike Wille; Eric N Villegas; Linden Craig; Robert Peach; Christopher A Hunter
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

3.  CD40-CD40 ligand (CD154) engagement is required but may not be sufficient for human T helper 1 cell induction of interleukin-2- or interleukin-15-driven, contact-dependent, interleukin-1beta production by monocytes.

Authors:  C Ribbens; J M Dayer; C Chizzolini
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

4.  TREM-1 modulation produces positive outcome on the histopathology and cytokines release profile of Plasmodium berghei-infected mice.

Authors:  Voon Kin Chin; Afiq Mohd Yusof Asyran; Zainul Amiruddin Zakaria; Wan Omar Abdullah; Pei Pei Chong; Norshariza Nordin; Zaid Osamah Ibraheem; Roslaini Abdul Majid; Rusliza Basir
Journal:  J Parasit Dis       Date:  2018-12-15

5.  Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice.

Authors:  E N Villegas; U Wille; L Craig; P S Linsley; D M Rennick; R Peach; C A Hunter
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

6.  Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection.

Authors:  Douglas E Jones; Mark R Ackermann; Ulrike Wille; Christopher A Hunter; Phillip Scott
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

7.  Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes.

Authors:  David H Wagner; Gisela Vaitaitis; Richard Sanderson; Michelle Poulin; Cathleen Dobbs; Kathryn Haskins
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

8.  Interleukin-4 enhances pulmonary clearance of Pseudomonas aeruginosa.

Authors:  S Jain-Vora; A M LeVine; Z Chroneos; G F Ross; W M Hull; J A Whitsett
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  CD40-CD154 interactions between macrophages and natural killer cells during sepsis are critical for macrophage activation and are not interferon gamma dependent.

Authors:  M J Scott; J J Hoth; M K Stagner; S A Gardner; J C Peyton; W G Cheadle
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

10.  Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality.

Authors:  W L William Chang; Nicole Baumgarth; Dong Yu; Peter A Barry
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.